View in EDS

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

Saved in:
Bibliographic Details
Title: The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.
Authors: Baďurová K; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Kapustová V; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Kotulová J; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Brinsa V; GeneSpector s.r.o., Prague, Czech Republic.; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic., Piherová L; GeneSpector s.r.o., Prague, Czech Republic.; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic., Janoušek V; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Biodviser Ltd, Oldham, Manchester, UK., Pohludka M; GeneSpector s.r.o., Prague, Czech Republic., Richtář M; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic., Jelínek T; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Hájek R; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Chyra Z; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Ševčíková T; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.
Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 475-494. Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41910939
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baďurová+K%22">Baďurová K</searchLink>; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kapustová+V%22">Kapustová V</searchLink>; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kotulová+J%22">Kotulová J</searchLink>; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Brinsa+V%22">Brinsa V</searchLink>; GeneSpector s.r.o., Prague, Czech Republic.; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Piherová+L%22">Piherová L</searchLink>; GeneSpector s.r.o., Prague, Czech Republic.; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Janoušek+V%22">Janoušek V</searchLink>; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Biodviser Ltd, Oldham, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Pohludka+M%22">Pohludka M</searchLink>; GeneSpector s.r.o., Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Richtář+M%22">Richtář M</searchLink>; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Jelínek+T%22">Jelínek T</searchLink>; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hájek+R%22">Hájek R</searchLink>; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Chyra+Z%22">Chyra Z</searchLink>; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Ševčíková+T%22">Ševčíková T</searchLink>; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101264260%22">Molecular diagnosis & therapy</searchLink> [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 475-494. <i>Date of Electronic Publication: </i>2026 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101264260 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2000 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211771062%22">11771062 </searchLink><i>NLM ISO Abbreviation: </i>Mol Diagn Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41910939
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40291-026-00836-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 475
    Titles:
      – TitleFull: The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baďurová K
      – PersonEntity:
          Name:
            NameFull: Kapustová V
      – PersonEntity:
          Name:
            NameFull: Kotulová J
      – PersonEntity:
          Name:
            NameFull: Brinsa V
      – PersonEntity:
          Name:
            NameFull: Piherová L
      – PersonEntity:
          Name:
            NameFull: Janoušek V
      – PersonEntity:
          Name:
            NameFull: Pohludka M
      – PersonEntity:
          Name:
            NameFull: Richtář M
      – PersonEntity:
          Name:
            NameFull: Jelínek T
      – PersonEntity:
          Name:
            NameFull: Hájek R
      – PersonEntity:
          Name:
            NameFull: Chyra Z
      – PersonEntity:
          Name:
            NameFull: Ševčíková T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2000
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular diagnosis & therapy
              Type: main
ResultId 1